Travere Therapeutics
TVTX
TVTX
174 hedge funds and large institutions have $677M invested in Travere Therapeutics in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 64 increasing their positions, 48 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $807M → $677M (-$129M)
81% less call options, than puts
Call options by funds: $1.09M | Put options by funds: $5.82M
Holders
174
Holding in Top 10
–
Calls
$1.09M
Puts
$5.82M
Top Buyers
| 1 | +$9.69M | |
| 2 | +$7.37M | |
| 3 | +$7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.72M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.79M |
Top Sellers
| 1 | -$36.6M | |
| 2 | -$9.84M | |
| 3 | -$7.43M | |
| 4 |
Goldman Sachs
New York
|
-$5.95M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$5.72M |